- Home
- Iron Deficiency Anemia
- Information for Patients
- About Anemia
- About Iron
- Iron Absorption:
- Forms of Iron:
- Dietary Iron:
- Dietary Iron Overview
- Iron-Rich Foods
- Iron in Baby Food
- Iron in Baked Products
- Iron in Beef and Beef Products
- Iron in Cereal Grains and Pasta
- Iron in Dairy and Egg Products
- Iron in Fish and Shellfish Products
- Iron in Fruits and Fruit Juices
- Iron in Herbs and Spices
- Iron in Lamb, Veal, and Wild Game
- Iron in Legumes and Legume Products
- Iron in Nuts and Seeds
- Iron in Pork and Pork Products
- Iron in Chicken, Turkey, and Other Poultry Products
- Iron in Sausages and Lunch Meat
- Iron in Soups, Sauces and Gravies
- Iron in Vegetables and Vegetable Products A-O
- Iron in Vegetables and Vegetable Products P-Z
- Effect of Foods on Non-Heme Iron Absorption
- About Ferralet
- Information for Healthcare Professionals
- Press/Media
- Legal/Privacy
- Report an Adverse Event
- Contact
Important Safety Information
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Warning
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions
Administration of Drug- General: Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with Ferralet® 90 tablets. Ensure Hgb, Hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. Periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
- Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using these products since folic acid may mask the symptoms of pernicious anemia.
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use: Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
